Sensei Biotherapeutics
SNSE
SNSE
26 hedge funds and large institutions have $3.92M invested in Sensei Biotherapeutics in 2022 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 4 increasing their positions, 11 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
less ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
64% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 11
Holders
26
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$1.1M | |
| 2 | +$68.7K | |
| 3 | +$39K | |
| 4 |
DCM
Deuterium Capital Management
Clearwater,
Florida
|
+$17.7K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$17.6K |
Top Sellers
| 1 | -$1.06M | |
| 2 | -$204K | |
| 3 | -$82.9K | |
| 4 |
HighTower Advisors
Chicago,
Illinois
|
-$78K |
| 5 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$74.5K |